Intuitive Surgical Shares Rebound After Q2 Revenue Miss Concerns
Intuitive Surgical reported Q2 revenue of $2.89 billion, up 18.5% year over year, but shares fell the next day on cautious procedure growth guidance and a Class II recall of Da Vinci components. The stock hit a low of $328.57 on July 23, then rebounded. On Tuesday, shares rose 5.7% to $356.83, with technical indicators suggesting a short-term reversal.
However, the company's shares fell sharply the next day due to cautious procedure growth guidance and a Class II recall involving some Da Vinci components. On July 23, the stock hit a low of $328.57, before rebounding on July 24. This Tuesday, Intuitive Surgical shares rose 5.7% to $356.83.
From a technical standpoint, the MACD (5,13,5) indicator showed a golden cross on Tuesday, but the MACD line remains deeply negative at around -16, suggesting a recent reversal rather than a mature trend. The Relative Strength Index (RSI) fell below the 30 oversold line on July 23, then recovered above 30 the next day, confirming a halt in selling. In the Directional Movement Index (DMI), the negative directional indicator DI- remains above the positive DI+ (36 versus 22), but the two lines have been converging since the July 23 low, typically seen as an early sign of a shift in trend structure. Volume has remained at two to three times pre-earnings levels since July 17, indicating genuine buying interest.